• S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

  • Apr 11 2022
  • Length: 23 mins
  • Podcast

S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

  • Summary

  • In this episode, our faculty looks at the latest treatments for multiple sclerosis—the newest sphingosine-1-phosphate receptor modulators. What is their mechanism of action? Which patients would benefit from them, and how are side effects and toxicities managed with these latest treatment options?

    Visit www.morningcommutepodcast.com/ms8 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.